Reduction in oral corticosteroid use in patients with severe allergic (IgE-mediated) asthma receiving omalizumab in a real-world setting

Detalles Bibliográficos
Autores principales: Braunstahl, Gert-Jan, Chlumsky, Jan, Peachey, Guy, Maykut, Robert, Chen, Chien-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3647332/
http://dx.doi.org/10.1186/2045-7022-3-S1-P13
_version_ 1782268720572268544
author Braunstahl, Gert-Jan
Chlumsky, Jan
Peachey, Guy
Maykut, Robert
Chen, Chien-Wei
author_facet Braunstahl, Gert-Jan
Chlumsky, Jan
Peachey, Guy
Maykut, Robert
Chen, Chien-Wei
author_sort Braunstahl, Gert-Jan
collection PubMed
description
format Online
Article
Text
id pubmed-3647332
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36473322013-05-10 Reduction in oral corticosteroid use in patients with severe allergic (IgE-mediated) asthma receiving omalizumab in a real-world setting Braunstahl, Gert-Jan Chlumsky, Jan Peachey, Guy Maykut, Robert Chen, Chien-Wei Clin Transl Allergy Poster Presentation BioMed Central 2013-05-03 /pmc/articles/PMC3647332/ http://dx.doi.org/10.1186/2045-7022-3-S1-P13 Text en Copyright © 2013 Braunstahl et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Braunstahl, Gert-Jan
Chlumsky, Jan
Peachey, Guy
Maykut, Robert
Chen, Chien-Wei
Reduction in oral corticosteroid use in patients with severe allergic (IgE-mediated) asthma receiving omalizumab in a real-world setting
title Reduction in oral corticosteroid use in patients with severe allergic (IgE-mediated) asthma receiving omalizumab in a real-world setting
title_full Reduction in oral corticosteroid use in patients with severe allergic (IgE-mediated) asthma receiving omalizumab in a real-world setting
title_fullStr Reduction in oral corticosteroid use in patients with severe allergic (IgE-mediated) asthma receiving omalizumab in a real-world setting
title_full_unstemmed Reduction in oral corticosteroid use in patients with severe allergic (IgE-mediated) asthma receiving omalizumab in a real-world setting
title_short Reduction in oral corticosteroid use in patients with severe allergic (IgE-mediated) asthma receiving omalizumab in a real-world setting
title_sort reduction in oral corticosteroid use in patients with severe allergic (ige-mediated) asthma receiving omalizumab in a real-world setting
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3647332/
http://dx.doi.org/10.1186/2045-7022-3-S1-P13
work_keys_str_mv AT braunstahlgertjan reductioninoralcorticosteroiduseinpatientswithsevereallergicigemediatedasthmareceivingomalizumabinarealworldsetting
AT chlumskyjan reductioninoralcorticosteroiduseinpatientswithsevereallergicigemediatedasthmareceivingomalizumabinarealworldsetting
AT peacheyguy reductioninoralcorticosteroiduseinpatientswithsevereallergicigemediatedasthmareceivingomalizumabinarealworldsetting
AT maykutrobert reductioninoralcorticosteroiduseinpatientswithsevereallergicigemediatedasthmareceivingomalizumabinarealworldsetting
AT chenchienwei reductioninoralcorticosteroiduseinpatientswithsevereallergicigemediatedasthmareceivingomalizumabinarealworldsetting

Ejemplares similares